Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
---|
12/19/1996 | CA2223033A1 High affinity human monoclonal antibodies specific for rsv f-protein |
12/19/1996 | CA2222999A1 Novel ctla4/cd28 ligands and uses therefor |
12/19/1996 | CA2222972A1 Reversible cysteine protease inhibitors |
12/19/1996 | CA2222947A1 Inhibin compositions and methods of enhancing production performance |
12/19/1996 | CA2222793A1 Optimized minizymes and miniribozymes and uses thereof |
12/19/1996 | CA2222789A1 Bone stimulating factor |
12/19/1996 | CA2222690A1 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits |
12/19/1996 | CA2222538A1 Apparatus and method for delivering a biologically active compound into a biological environment |
12/19/1996 | CA2222520A1 Oligonucleotides specific for cytokine signal transducer gp130 mrna |
12/19/1996 | CA2222239A1 A method of crosslinking amino acid-containing polymers using photoactivatable chemical cross-linkers |
12/19/1996 | CA2222231A1 Antibody and antibody fragments for inhibiting the growth of tumors |
12/19/1996 | CA2222183A1 Stable reagents for the preparation of radiopharmaceuticals |
12/19/1996 | CA2222162A1 Pericardial therapeutic and diagnostic agent delivery |
12/19/1996 | CA2222135A1 Hapten modified tumor cell extract and methods of treating or screening for cancer |
12/19/1996 | CA2222066A1 Hemodilution facilitated by monitoring oxygenation status |
12/19/1996 | CA2221821A1 Endothelial-monocyte activating polypeptide iii |
12/19/1996 | CA2221780A1 Anti-fungal d-amino acid histatin-based peptides |
12/19/1996 | CA2221710A1 Gene therapy for myocardial ischemia |
12/19/1996 | CA2221690A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
12/19/1996 | CA2221646A1 Synthetic peptides and pharmaceutical compositions comprising them |
12/19/1996 | CA2221602A1 Essential oligonucleotides of vertebrate telomerase |
12/19/1996 | CA2221601A1 Regulation of cytokine synthesis and release |
12/19/1996 | CA2221570A1 Neutralizing conformation epitopes of chicken anemia virus |
12/19/1996 | CA2221480A1 Mutants of streptococcal toxin a and methods of use |
12/19/1996 | CA2221146A1 Structurally determined metallo-constructs and applications |
12/19/1996 | CA2220957A1 Glycine and phaseolus .alpha.-d-galactosidases |
12/19/1996 | CA2220952A1 Anti-allergy bispecific molecules |
12/19/1996 | CA2220714A1 A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
12/19/1996 | CA2219980A1 Method for inhibiting neoplastic disease in mammals |
12/19/1996 | CA2219457A1 Oral tolerance in skin diseases presenting with t-cell mediated inflammation |
12/19/1996 | CA2219242A1 Modified hemoglobin-like compounds and methods of purifying same |
12/19/1996 | CA2197244A1 Wound healing formulations containing human plasma fibronectin |
12/19/1996 | CA2196691A1 Macrophage derived chemokine and chemokine analogs |
12/19/1996 | CA2196334A1 Urokinase receptor ligands |
12/18/1996 | EP0748870A2 Oncostatin M induced hematopoiesis |
12/18/1996 | EP0748817A2 Parathyroid hormone derivatives and their use |
12/18/1996 | EP0748816A1 Toxoplasma gondii antigen, its production and use |
12/18/1996 | EP0748815A1 Toxoplasma gondii antigen, its production and use |
12/18/1996 | EP0748633A2 Adhesive tissue and its use as haemostyptic |
12/18/1996 | EP0748631A2 Viral vaccines |
12/18/1996 | EP0748630A1 Urinastatin-containing suppository |
12/18/1996 | EP0748591A1 Fluorinated micellar casein |
12/18/1996 | EP0748385A1 Integrative recombinant adenoviruses, preparation thereof and therapeutical uses thereof |
12/18/1996 | EP0748384A1 Transgenic plants for the control of animal parasites |
12/18/1996 | EP0748383A1 Targeted cleavage of rna using ribonuclease p targeting and cleavage sequences |
12/18/1996 | EP0748380A1 KUNITZ DOMAIN INHIBITOR PROTEINS DERIVED FROM ALZHEIMER'S AMYLOID $g(b)-PROTEIN PRECURSOR INHIBITOR |
12/18/1996 | EP0748377A1 IMPROVED DNase LIQUID SOLUTIONS |
12/18/1996 | EP0748376A1 Rna editing enzyme and methods of use thereof |
12/18/1996 | EP0748374A1 Method for preparing clonogenic fibroblasts, method for gene transfection of fibroblasts and gene-transfected fibroblasts so obtained |
12/18/1996 | EP0748338A1 In vitro antibody affinity maturation using alanine scanning mutagenesis |
12/18/1996 | EP0748337A1 Process for the obtention of a biological adhesive comprising fibrinogen, factor xiii and fibronectin |
12/18/1996 | EP0748336A1 Immunosuppressive compounds and method of preparing same |
12/18/1996 | EP0748335A1 Antibiotic stalobacins |
12/18/1996 | EP0748333A1 Antithrombotic agents |
12/18/1996 | EP0748226A1 Block copolymers |
12/18/1996 | EP0748225A1 PHARMACEUTICALLY ACCEPTABLE DNase FORMULATION |
12/18/1996 | EP0748219A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
12/18/1996 | EP0748217A1 Compositions comprising a mast cell degranulation-blocking agent for treatment of endogenous, painful gastrointestinal conditions of non-inflammatory, non-ulcerative origin |
12/18/1996 | EP0748215A1 Biologic bioadhesive compositions containing fibrin glue and liposomes, methods of preparation and use |
12/18/1996 | EP0748213A1 Methods and compositions for pulmonary delivery of insulin |
12/18/1996 | EP0748191A1 Methods and formulations for use in treating oophorectomized women |
12/18/1996 | EP0748190A1 Methods and formulations for use in treating benign gynecological disorders |
12/18/1996 | EP0695171B1 Lyospheres comprising gonadotropin |
12/18/1996 | EP0662147B1 Small cell lung carcinoma specific antibody and antigen |
12/18/1996 | EP0621774B1 Improved process for preparing micronized polypeptide drugs |
12/18/1996 | EP0618802A4 Synthetic compounds and compositions with enhanced cell binding. |
12/18/1996 | EP0609242B1 New thrombin-inhibiting protein isolated from ticks |
12/18/1996 | EP0555479B1 Epoxysuccinamic acid derivative |
12/18/1996 | EP0554284B1 Peptide-based inhibitors of hiv replication |
12/18/1996 | EP0526608B1 Therapeutic agents for the treatment of multidrug resistance to cancers |
12/18/1996 | CN1138350A CNTF Family antagonists |
12/18/1996 | CN1138349A Human activated protein C preparation and process for producing the same |
12/18/1996 | CN1138335A Compounds with growth hormone releasing properties |
12/18/1996 | CN1138334A Compounds with growth hormone releasing properties |
12/18/1996 | CN1138297A Method of stabilizing protein C or activated protein C and stabilized composition |
12/18/1996 | CN1138295A A novel tumor suppressor gene |
12/18/1996 | CN1033584C Benzo-fused lactams that promote release of growth hormone |
12/17/1996 | US5585499 Drug delivery |
12/17/1996 | US5585486 Peptidic ketones as interleukin-1β-converting enzyme inhibitors |
12/17/1996 | US5585484 Using ethoxylated phenylmaleimido compounds |
12/17/1996 | US5585479 Useful for the treatment of septic shock and inflammatory complications of shock |
12/17/1996 | US5585478 D4 gene and methods of use thereof |
12/17/1996 | US5585475 Does not exhibit strict alpha-helical conformations |
12/17/1996 | US5585474 DNA encoding protein possessing metastasis-inhibitory activity |
12/17/1996 | US5585467 Cultivating a mycins from fungus strain |
12/17/1996 | US5585464 Recombinant antigen for diagnosing rheumatoid arthritis |
12/17/1996 | US5585463 β3 integrin subunit specific polypeptides, cDNAs which encode these polypeptides and method of producing these polypeptides |
12/17/1996 | US5585461 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
12/17/1996 | US5585397 Viricides |
12/17/1996 | US5585376 1,5-benzodiazepine derivatives having CCK and/or gastrin antagonistic activity |
12/17/1996 | US5585362 Adenovirus vectors for gene therapy |
12/17/1996 | US5585361 Intravenous administration of hyaluronic acid or its salts |
12/17/1996 | US5585360 Thrombin inhibitors |
12/17/1996 | US5585359 Inhibitors of farnesyl-protein transferase |
12/17/1996 | US5585357 Heteroaryloxymethyl ketones as interleukin-1βconverting enzyme inhibitors |
12/17/1996 | US5585356 Matrix metalloproteinase peptides: role in diagnosis and therapy |
12/17/1996 | US5585355 Drug delivery with a bradykinin derivatives |
12/17/1996 | US5585354 Suppressant of corneal subepithelial clouding |
12/17/1996 | US5585353 Antibiotic peptides containing D-amino acids |
12/17/1996 | US5585352 Method of treating septic shock using thymosin-α 1 |